Searched for
KOTHUR FORMULATION FACILITY
NATCO Pharma shares sinks 28% in 2 days on Q3 earnings miss, brokerage downgradeNATCO Pharma shares tumbled 10% on Friday, extending a two-day slump to 28% after weak Q3 results and a target price cut by Nuvama. Profit ...- Natco Pharma gets warning letter from USFDA for Telangana plantNatco Pharma, a pharmaceutical company, received a warning letter from the USFDA regarding its manufacturing plant in Telangana. This came ...
- Natco Pharma gets EIR from USFDA for Telangana facilityThe United States Food and Drug Administration (USFDA) had conducted pre-approval inspection at the company's drug formulations facility in...
- Worst is over for the pharma sector. What investors should doThough short-term pressure will continue, risk-reward is getting in favour of this sector.
- USFDA issues 9 observations to Natco Pharma's Kothur facility"At the end of the inspection, the facility received 9 observations, with no repeat observations and mostly procedural in nature," Natco Ph...
- USFDA makes 6 observations at Natco Pharma's Kothur facilityNatco Pharma said it will provide due justifications and corrective action plan within next 15 working days to the address the USFDA observ...
- Natco Pharma stock plunges 13% on USFDA observationsShares of Natco Pharma plummeted 13 per cent today after the company received 483 observations from the USFDA after inspection of its two f...
- Natco Pharma plunges as USFDA issues form 483 to the companyReacting to the development, the stock slumped 10.94 per cent to hit a low of Rs 417.10 on the BSE. The stock has plunged 26 per cent in th...
- USFDA observations on 2 units not to impact products: Natco"The company has received 483 observations for both facilities and believes them to be of minor in nature," a statement said.
Load More
